Elekta AB, founded in 1972 and headquartered in Stockholm, Sweden, is a prominent medical technology company focused on providing innovative solutions for cancer care and brain disorders. The company specializes in advanced radiation therapy, software for treatment planning, and integrated solutions for oncology management.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| EKTAB 3.41% 2026-12-14 SEKElekta AB | Sweden | 2026-12-14 | 3.410 | 2.85 |
| EKTAB 3.85% 2025-03-13 SEKElekta AB | Sweden | 2025-03-13 | 3.854 | 0.00 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Elekta has a history of active bond issuances, first entering the bond market in 2014 to support its growth initiatives. Notably, the company issued a SEK 1 billion bond in 2020, aimed at refinancing existing debt and funding future acquisitions, which showcased a yield of approximately 3.5%—competitive against the medical device industry average. In recent news, Elekta plans to issue green bonds, aligning with its sustainability goals, further enhancing its appeal to socially responsible investors.